Dow stock falls toward analyst low target amid mixed ratings

Published on 09/20/2026 at 13:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dow stock trades at a discount to consensus targets as of September 20, 2026, with the price near a key analyst low. Recent cost-cutting plans and distribution deals frame the fundamental story and risks for investors.

Photorealistic panoramic view of a large petrochemical plant at sunset, illuminated distillation towers and pipelines glowing amber and orange against a dramatic sky with purples and crimsons, reflections visible in foreground cooling ponds — Dow Inc. US2605571031 zeigt eine Groß chemieanlage mit beleuchteten Türmen und Rohren bei Sonnenuntergang, Illustration mit AI erstellt.

Dow Inc. stock (ISIN US2605571031) is trading below most analyst targets as of September 20, 2026, with the latest price of USD 28.73 on the New York Stock Exchange highlighting renewed pressure on the chemicals group’s valuation. As of September 20, 2026, the shares sit close to an analyst low target of USD 28.00, underlining the cautious tone in recent coverage.

Analyst views split as price nears low target

According to Pluang on September 20, 2026, Dow stock trades at USD 28.73, down 4.49% on the day, which places it just 2.6% above the cited analyst low target of USD 28.00 in the same overview. With a consensus price target of USD 34.78, this implies roughly 21% upside from the current level, signaling that the market price is materially below where many analysts expect the stock to trade over the next 12 months.

The same data show that only 30.6% of recommendations on Dow are currently in the buy category, while the remainder are hold or sell ratings, illustrating a mixed stance toward the stock despite the gap to consensus targets. For investors, the key tension is that valuation appears undemanding compared with analyst models, yet the limited share of buy ratings points to concerns about cyclical demand, margins and cash generation in a higher-rate environment.

Cost-cutting program reshapes the fundamental story

Beyond the price action, the company’s internal efficiency drive is an important part of the fundamental backdrop. As Simply Wall St reported on September 20, 2026, Dow is pursuing a Transform to Outperform program that targets about USD 700 million of savings in the current year and a total of USD 2 billion over the life of the initiative. These figures, framed for the 2026 financial year, represent a significant efficiency effort when set against Dow’s historical annual operating cost base, and they are designed to protect margins in a chemicals sector facing higher input costs and uneven end-market demand.

In parallel, Univar Solutions USA LLC has expanded its agreement with Dow to distribute SupraCare polymers and specialty additives for homecare and industrial cleaning formulators across the United States and Canada, widening access to Dow’s specialty ingredients portfolio, according to Simply Wall St on September 20, 2026. That broader distribution reach can help shift Dow’s mix toward higher-value specialty products, which typically command better margins than bulk commodity chemicals.

Rating changes and consensus context

Recent analyst actions add nuance to the picture. A European-traded line of Dow has seen KeyBanc initiate coverage at Sector Weight, reflecting a neutral stance on the shares. As MSN summarized on September 20, 2026, the current recommendation period for September 1, 2026 includes 24 analyst opinions on Dow, with 4 strong buy, 7 buy, 11 hold and 2 sell recommendations. This distribution translates into 45.8% positive (strong buy plus buy), 45.8% hold and 8.3% negative views, unchanged compared with the August 1, 2026 recommendation period.

That stability in the recommendation mix, combined with the current price near the low end of the target range, suggests that analysts broadly see limited near-term catalysts but are not yet turning decisively bearish. The consensus target around USD 34.78, compared with the USD 28.73 spot price cited by Pluang, implies an upside of about 21%, but the neutral weighting by houses like KeyBanc points to the possibility that this upside may take time to materialize and could depend on Dow delivering the planned USD 700 million of cost savings for 2026.

Macro headwinds from higher yields

Dow’s share performance also needs to be viewed in the wider context of U.S. equities under pressure from rising interest rates and government bond yields. The Dow Jones Industrial Average, which includes Dow Inc. as one of its components, has been moving lower in recent weeks as sovereign yields climbed above 5% on key benchmarks. As Mixvale reported on September 19, 2026, the Dow Jones Industrial Average slid toward its third consecutive weekly decline on September 18, 2026 at 1:22 p.m. ET as government debt yields surged across global credit markets.

Further detail from a market report on September 20, 2026 shows that the Dow Jones Industrial Average fell by 890.65 points in the week from the close of 52,573.29 on September 11, 2026 to 51,682.64 on September 18, 2026, a decline of about 1.69%, according to Note. In that environment, cyclical and dividend-paying stocks such as large chemicals producers have tended to lag technology names, which helps explain why Dow’s share price is under pressure even as it pursues structural cost reductions.

Stock price level and market metrics

On the New York Stock Exchange, Dow stock most recently traded at USD 28.73 as of September 20, 2026, per data cited by Pluang, with the day’s move of -4.49% pointing to renewed selling interest after the Federal Reserve’s latest rate hike. With the consensus analyst target at USD 34.78 and the cited low target at USD 28.00, the current price stands roughly 21% below the average expectation but only slightly above the most cautious target, illustrating how the market is pricing in both macro and company-specific risks.